Stanford University
Showing 25,501-25,520 of 36,216 Results
-
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Cara Rada
Postdoctoral Scholar, Hematology
Current Research and Scholarly InterestsI develop human brain models to study neurological infection, cancer metastasis, and neurodegeneration. My research focuses on the brain’s blood vessels and brain resident immune cell, microglia, and investigates how alterations in these components of the brain microenvironment can have deleterious effects.
-
Heather Radford, PA-C
Affiliate, IT Services
BioHeather Radford, PA-C is the Lead Advanced Practice Provider for the Blood and Marrow Transplant Program. She completed her MHS and PA studies at Duke University in 2007. She then started her career in inpatient pulmonary and critical care at Johns Hopkins from 2007-2011. She transitioned her practice to the Johns Hopkins inpatient hematologic malignancies and Bone Marrow Transplant program from 2011-2013. She moved back west and landed in beautiful Palo Alto, California. She joined the Stanford BMT program in September 2013 and shortly thereafter was promoted to Lead APP. Her area of clinical practice is bone marrow transplant and cancer cellular therapies. She practices on the inpatient service as well l as the infusion treatment area in addition to her leadership role.
